speb/financial-data huggingface dataset:
ZYDUSWELL.NS income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
ZYDUSWELL.NS income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 1788000000.00
ZYDUSWELL.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1788000000.00
ZYDUSWELL.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -66000000.00
ZYDUSWELL.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -2544578.31
ZYDUSWELL.NS income_statement (quarterly, 2025-12-31) — Tax Provision: -16000000.00
ZYDUSWELL.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.04
ZYDUSWELL.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 9585000000.00
ZYDUSWELL.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -66000000.00
ZYDUSWELL.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -66000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — +Operating Expense: 20071000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 7464000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — +Total Revenue: 39400000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 14761000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 4614000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 4614000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 3838000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3838000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -2694000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -2694000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 35370000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 35370000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -40000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -40000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Amortization: 1196000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 1196000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 69000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 69000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 318271120.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 5.09
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 667000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 1938000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 1938000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1017000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 164000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 164000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 636000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 636000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1106000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1106000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1149000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1149000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -382000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 1106000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1106000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -748000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -538000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -353000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Change In Payable: -538000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 66000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -2111000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 149000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Common Stock: 636000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 636000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 58260000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 58260000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 231000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 231000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 15772000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 5197000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Current Assets: 13667000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 13667000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 43000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 43000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1515000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1515000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1558000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1558000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 7285000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 7285000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 392000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 392000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Depreciation: 271000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 1467000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 1467000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 553000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 271000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 553000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 318271120.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 5.09
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1972000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1620000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 4000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 4000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — EBIT: 3255000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — EBIT: 2160000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — EBITDA: 4722000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — EBITDA: 2713000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 19000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1106000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 26984000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 5307000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 5307000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 1247000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -38000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: 0.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 1000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 445000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Goodwill: 49419000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 49419000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 82806000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 82806000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 3878000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 3878000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 6078000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 6078000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Gross Profit: 23628000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 9564000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Held To Maturity Securities: 6000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 6000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Interest Expense: 950000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 387000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 950000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 387000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Interest Income: 14000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 14000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -868000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 14000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Inventory: 7638000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 7638000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 90124000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 90124000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -29099000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 6000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 6000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 28897000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 786000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 786000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 121000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 121000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 30349000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 30349000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 30470000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 30470000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 28897000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -253000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 3000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 3000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 294000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 294000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 3123000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 3123000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -28500000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Net Debt: 30758000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 30758000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -44000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Net Income: 1972000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Net Income: 1620000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1972000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1620000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1972000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1620000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1972000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1620000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1972000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1620000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 2305000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1972000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1620000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Net Interest Income: -967000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -387000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 420000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 28294000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 28644000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -967000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -387000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Net PPE: 3384000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 3384000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1009000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -350000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: -24546000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -24546000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 303000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 303000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 1179000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1179000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 6320000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 6320000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 294000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 294000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 2031000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 2031000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 5093000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 2713000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Normalized Income: 2289402169.20
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 1620000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 2264000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Operating Income: 3557000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Operating Income: 2100000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Operating Revenue: 39400000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 14761000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 318160720.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 318160720.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 271000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 544000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 544000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 418000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 418000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 57624000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 57624000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 33387000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 33387000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 962000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1870000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1870000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 12000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 12000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1663000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 3540000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Other Payable: 514000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 514000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Other Properties: 3153000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 3153000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 462000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 462000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 43000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 43000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Other Special Charges: 164000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Payables: 5133000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Payables: 5133000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 97000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 544000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 544000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Pretax Income: 2305000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 1773000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -76000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -28500000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1017000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 1287000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1287000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 15772000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 5197000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 1467000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 553000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 99000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 99000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -253000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 4000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 4000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 245000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 0.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 21849000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 21849000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Sale Of Business: 0.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 420000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 8000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 13058000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 2411000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 13503000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 2411000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Share Issued: 318160720.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 318160720.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Special Income Charges: -409000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 58260000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 58260000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: -24546000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -24546000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -53597830.80
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Tax Provision: 333000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 153000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.14
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.09
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 32000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 32000000.00
ZYDUSWELL.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -299000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Total Assets: 103078000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 103078000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 88609000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 88609000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Total Debt: 32028000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 32028000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 58260000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 58260000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Total Expenses: 35843000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 12661000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 44818000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 44818000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 89411000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 89411000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 37533000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 37533000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 31000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 1000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 1000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -371000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -371000000.00
ZYDUSWELL.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Work In Process: 1044000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 1044000000.00
ZYDUSWELL.NS balance_sheet (annual, 2026-03-31) — Working Capital: 6382000000.00
ZYDUSWELL.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 6382000000.00
ZYDUSWELL.NS income_statement (annual, 2026-03-31) — Write Off: 0.00
ZYME cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -17000.00
ZYME cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -17000.00
ZYME cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -17000.00
ZYME balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 12490000.00
ZYME cash_flow (annual, 2021-12-31) — Other Non Cash Items: 213000.00
ZYME balance_sheet (annual, 2021-12-31) — Other Payable: 2242000.00
ZYME income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 28534000.00
ZYME balance_sheet (annual, 2021-12-31) — Prepaid Assets: 19998000.00
ZYME cash_flow (annual, 2021-12-31) — Repayment Of Debt: -17000.00
ZYME income_statement (annual, 2022-12-31) — +Operating Expense: 281996000.00
ZYME income_statement (annual, 2022-12-31) — +Total Revenue: 412482000.00
ZYME balance_sheet (annual, 2022-12-31) — Accounts Payable: 7863000.00
ZYME balance_sheet (annual, 2022-12-31) — Accounts Receivable: 33400000.00
ZYME balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -13299000.00
ZYME balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 151614000.00
ZYME cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 1015000.00
ZYME cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 1015000.00
ZYME cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
ZYME income_statement (annual, 2022-12-31) — Average Dilution Earnings: -231000.00
ZYME income_statement (annual, 2022-12-31) — Basic Average Shares: 65194775.00
ZYME income_statement (annual, 2022-12-31) — Basic EPS: 1.91
ZYME cash_flow (annual, 2022-12-31) — Beginning Cash Position: 201867000.00
ZYME cash_flow (annual, 2022-12-31) — Capital Expenditure: -13125000.00
ZYME balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 28113000.00
ZYME balance_sheet (annual, 2022-12-31) — Capital Stock: 906764000.00
ZYME balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 400912000.00
ZYME balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 492232000.00
ZYME cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 108582000.00
ZYME cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -53849000.00
ZYME cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 144109000.00
ZYME cash_flow (annual, 2022-12-31) — Change In Account Payable: 26479000.00
ZYME cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 840000.00
ZYME cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -3736000.00
ZYME cash_flow (annual, 2022-12-31) — Change In Payable: 27319000.00
ZYME cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 27319000.00
ZYME cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -2059000.00
ZYME cash_flow (annual, 2022-12-31) — Change In Receivables: -17509000.00
ZYME cash_flow (annual, 2022-12-31) — Change In Tax Payable: 840000.00
ZYME cash_flow (annual, 2022-12-31) — Change In Working Capital: 4015000.00
ZYME cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -17509000.00
ZYME cash_flow (annual, 2022-12-31) — Changes In Cash: 198842000.00
ZYME balance_sheet (annual, 2022-12-31) — Common Stock: 906764000.00
ZYME balance_sheet (annual, 2022-12-31) — Common Stock Equity: 492956000.00
ZYME cash_flow (annual, 2022-12-31) — Common Stock Issuance: 107534000.00
ZYME cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
ZYME balance_sheet (annual, 2022-12-31) — Construction In Progress: 76000.00
ZYME balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 47157000.00
ZYME balance_sheet (annual, 2022-12-31) — Current Assets: 544706000.00
ZYME balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 3322000.00
ZYME balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3322000.00
ZYME balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 2353000.00
ZYME balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 2353000.00
ZYME balance_sheet (annual, 2022-12-31) — Current Liabilities: 95625000.00
ZYME cash_flow (annual, 2022-12-31) — Deferred Income Tax: 1940000.00
ZYME cash_flow (annual, 2022-12-31) — Deferred Tax: 1940000.00
ZYME cash_flow (annual, 2022-12-31) — Depreciation: 10989000.00
ZYME cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 12004000.00
ZYME cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 12004000.00
ZYME income_statement (annual, 2022-12-31) — Diluted Average Shares: 65249184.00
ZYME income_statement (annual, 2022-12-31) — Diluted EPS: 1.90
ZYME income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 124110000.00
ZYME income_statement (annual, 2022-12-31) — EBIT: 130486000.00
ZYME income_statement (annual, 2022-12-31) — EBITDA: 142490000.00
ZYME cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 203000.00
ZYME cash_flow (annual, 2022-12-31) — End Cash Position: 400912000.00
ZYME cash_flow (annual, 2022-12-31) — Financing Cash Flow: 108582000.00
ZYME cash_flow (annual, 2022-12-31) — Free Cash Flow: 130984000.00
ZYME income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 1152000.00
ZYME balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -6659000.00
ZYME income_statement (annual, 2022-12-31) — General And Administrative Expense: 73400000.00
ZYME balance_sheet (annual, 2022-12-31) — Goodwill: 12016000.00
ZYME balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 38399000.00
ZYME balance_sheet (annual, 2022-12-31) — Gross PPE: 60949000.00
ZYME income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
ZYME cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 10000000.00
ZYME balance_sheet (annual, 2022-12-31) — Income Tax Payable: 840000.00
ZYME income_statement (annual, 2022-12-31) — Interest Income: 3596000.00
ZYME income_statement (annual, 2022-12-31) — Interest Income Non Operating: 3596000.00
ZYME balance_sheet (annual, 2022-12-31) — Invested Capital: 492956000.00
ZYME cash_flow (annual, 2022-12-31) — Investing Cash Flow: -53849000.00
ZYME balance_sheet (annual, 2022-12-31) — Investments And Advances: 886000.00
ZYME cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 107534000.00
ZYME balance_sheet (annual, 2022-12-31) — Leases: 20960000.00
ZYME balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 24791000.00
ZYME balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 24791000.00
ZYME cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -14000.00
ZYME balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 7278000.00
ZYME cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 107534000.00
ZYME cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -1956000.00
ZYME income_statement (annual, 2022-12-31) — Net Income: 124341000.00
ZYME income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 124341000.00
ZYME income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 124341000.00
ZYME income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 124341000.00
ZYME income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 124341000.00
ZYME cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 124341000.00
ZYME income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 124341000.00
ZYME cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -4975000.00
ZYME income_statement (annual, 2022-12-31) — Net Interest Income: 3596000.00
ZYME cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -40724000.00
ZYME cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -14000.00
ZYME cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -14000.00
ZYME income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 3596000.00
ZYME cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -596000.00
ZYME balance_sheet (annual, 2022-12-31) — Net PPE: 47650000.00
ZYME cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -8150000.00
ZYME balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 454557000.00
ZYME balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 1355000.00
ZYME balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 32376000.00
ZYME balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 30588000.00
ZYME balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 1345000.00
ZYME balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 1788000.00
ZYME balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 15729000.00
ZYME income_statement (annual, 2022-12-31) — Normalized EBITDA: 141338000.00
ZYME income_statement (annual, 2022-12-31) — Normalized Income: 123281792.76
ZYME cash_flow (annual, 2022-12-31) — Operating Cash Flow: 144109000.00
ZYME cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1956000.00
ZYME income_statement (annual, 2022-12-31) — Operating Income: 130486000.00
ZYME income_statement (annual, 2022-12-31) — Operating Revenue: 412482000.00
ZYME balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 63059501.00
ZYME balance_sheet (annual, 2022-12-31) — Other Current Assets: 19074000.00
ZYME balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1642000.00
ZYME balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -6659000.00
ZYME income_statement (annual, 2022-12-31) — Other Gand A: 49600000.00
ZYME income_statement (annual, 2022-12-31) — Other Income Expense: 1110000.00
ZYME balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 26383000.00
ZYME cash_flow (annual, 2022-12-31) — Other Non Cash Items: -250000.00
ZYME balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 2977000.00
ZYME income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -42000.00
ZYME balance_sheet (annual, 2022-12-31) — Other Payable: 1839000.00
ZYME balance_sheet (annual, 2022-12-31) — Other Properties: 32635000.00
ZYME balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 91320000.00
ZYME income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 231000.00
ZYME balance_sheet (annual, 2022-12-31) — Payables: 26786000.00
ZYME balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 73943000.00
ZYME balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 14365000.00
ZYME balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
ZYME income_statement (annual, 2022-12-31) — Pretax Income: 135234000.00
ZYME cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1658000.00
ZYME balance_sheet (annual, 2022-12-31) — Properties: 0.00
ZYME cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -4975000.00
ZYME cash_flow (annual, 2022-12-31) — Purchase Of Investment: -113005000.00
ZYME cash_flow (annual, 2022-12-31) — Purchase Of PPE: -8150000.00
ZYME balance_sheet (annual, 2022-12-31) — Receivables: 33400000.00
ZYME income_statement (annual, 2022-12-31) — Reconciled Depreciation: 12004000.00
ZYME cash_flow (annual, 2022-12-31) — Repayment Of Debt: -14000.00
ZYME cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
ZYME income_statement (annual, 2022-12-31) — Research And Development: 208596000.00
ZYME balance_sheet (annual, 2022-12-31) — Retained Earnings: -558763000.00
ZYME income_statement (annual, 2022-12-31) — Salaries And Wages: 23800000.00
ZYME cash_flow (annual, 2022-12-31) — Sale Of Investment: 72281000.00
ZYME income_statement (annual, 2022-12-31) — Selling General And Administration: 73400000.00
ZYME balance_sheet (annual, 2022-12-31) — Share Issued: 63059501.00
ZYME income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
ZYME cash_flow (annual, 2022-12-31) — Stock Based Compensation: 4015000.00
ZYME balance_sheet (annual, 2022-12-31) — Stockholders Equity: 492956000.00
ZYME balance_sheet (annual, 2022-12-31) — Tangible Book Value: 454557000.00
ZYME income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 92792.76
ZYME income_statement (annual, 2022-12-31) — Tax Provision: 10893000.00
ZYME income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.08
ZYME balance_sheet (annual, 2022-12-31) — Total Assets: 648725000.00
ZYME balance_sheet (annual, 2022-12-31) — Total Capitalization: 492956000.00
ZYME balance_sheet (annual, 2022-12-31) — Total Debt: 28113000.00
ZYME balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 492956000.00
ZYME income_statement (annual, 2022-12-31) — Total Expenses: 281996000.00
ZYME balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 155769000.00
ZYME balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 104019000.00
ZYME balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 60144000.00
ZYME income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 130528000.00
ZYME balance_sheet (annual, 2022-12-31) — Total Tax Payable: 17084000.00
ZYME income_statement (annual, 2022-12-31) — Total Unusual Items: 1152000.00
ZYME income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 1152000.00
ZYME cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
ZYME balance_sheet (annual, 2022-12-31) — Working Capital: 449081000.00
ZYME income_statement (annual, 2023-12-31) — +Operating Expense: 214019000.00
ZYME income_statement (annual, 2023-12-31) — +Total Revenue: 76012000.00
ZYME balance_sheet (annual, 2023-12-31) — Accounts Payable: 6212000.00
ZYME balance_sheet (annual, 2023-12-31) — Accounts Receivable: 19477000.00
ZYME balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -20656000.00
ZYME balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 142274000.00
ZYME cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 2702000.00
ZYME cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 2702000.00
ZYME cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
ZYME income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
ZYME income_statement (annual, 2023-12-31) — Basic Average Shares: 68863010.00
ZYME income_statement (annual, 2023-12-31) — Basic EPS: -1.72
ZYME cash_flow (annual, 2023-12-31) — Beginning Cash Position: 400912000.00
ZYME cash_flow (annual, 2023-12-31) — Capital Expenditure: -4077000.00
ZYME balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 26722000.00
ZYME balance_sheet (annual, 2023-12-31) — Capital Stock: 1006572000.00
ZYME balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 157557000.00
ZYME balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 374327000.00
ZYME cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 81868000.00
ZYME cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -207253000.00
ZYME cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -118324000.00
ZYME cash_flow (annual, 2023-12-31) — Change In Account Payable: -44789000.00
ZYME cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 970000.00
ZYME cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -3663000.00
ZYME cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 3699000.00
ZYME cash_flow (annual, 2023-12-31) — Change In Payable: -43819000.00
ZYME cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -43819000.00
ZYME cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 4295000.00
ZYME cash_flow (annual, 2023-12-31) — Change In Receivables: 13922000.00
ZYME cash_flow (annual, 2023-12-31) — Change In Tax Payable: 970000.00
ZYME cash_flow (annual, 2023-12-31) — Change In Working Capital: -25566000.00
ZYME cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 13922000.00
ZYME cash_flow (annual, 2023-12-31) — Changes In Cash: -243709000.00
ZYME balance_sheet (annual, 2023-12-31) — Common Stock: 1006572000.00
ZYME balance_sheet (annual, 2023-12-31) — Common Stock Equity: 464806000.00
ZYME cash_flow (annual, 2023-12-31) — Common Stock Issuance: 76095000.00
ZYME cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
ZYME balance_sheet (annual, 2023-12-31) — Construction In Progress: 122000.00
ZYME balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 31097000.00
ZYME balance_sheet (annual, 2023-12-31) — Current Assets: 412926000.00
ZYME balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 4261000.00
ZYME balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4261000.00
ZYME balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 3699000.00
ZYME balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 3699000.00
ZYME balance_sheet (annual, 2023-12-31) — Current Liabilities: 55763000.00
ZYME cash_flow (annual, 2023-12-31) — Deferred Income Tax: -757000.00
ZYME cash_flow (annual, 2023-12-31) — Deferred Tax: -757000.00
ZYME cash_flow (annual, 2023-12-31) — Depreciation: 14603000.00
ZYME cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 17305000.00
ZYME cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 17305000.00
ZYME income_statement (annual, 2023-12-31) — Diluted Average Shares: 68863010.00
ZYME income_statement (annual, 2023-12-31) — Diluted EPS: -1.72
ZYME income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -118674000.00
ZYME income_statement (annual, 2023-12-31) — EBIT: -138007000.00
ZYME income_statement (annual, 2023-12-31) — EBITDA: -120702000.00
ZYME cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 354000.00
ZYME cash_flow (annual, 2023-12-31) — End Cash Position: 157557000.00
ZYME cash_flow (annual, 2023-12-31) — Financing Cash Flow: 81868000.00
ZYME cash_flow (annual, 2023-12-31) — Free Cash Flow: -122401000.00
ZYME income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -1185000.00
ZYME balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -6603000.00
ZYME income_statement (annual, 2023-12-31) — General And Administrative Expense: 70400000.00
ZYME balance_sheet (annual, 2023-12-31) — Goodwill: 12016000.00
ZYME balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 37300000.00
ZYME balance_sheet (annual, 2023-12-31) — Gross PPE: 58199000.00
ZYME income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
ZYME cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 165000.00
ZYME balance_sheet (annual, 2023-12-31) — Income Tax Payable: 1811000.00
ZYME income_statement (annual, 2023-12-31) — Interest Income: 19705000.00
ZYME income_statement (annual, 2023-12-31) — Interest Income Non Operating: 19705000.00
ZYME balance_sheet (annual, 2023-12-31) — Invested Capital: 464806000.00
ZYME cash_flow (annual, 2023-12-31) — Investing Cash Flow: -207253000.00
ZYME balance_sheet (annual, 2023-12-31) — Investments And Advances: 81930000.00
ZYME cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 76095000.00
ZYME balance_sheet (annual, 2023-12-31) — Leases: 20992000.00
ZYME balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 22461000.00
ZYME balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 22461000.00
ZYME cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -21000.00
ZYME balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 7582000.00
ZYME cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 76095000.00
ZYME cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -31000.00
ZYME income_statement (annual, 2023-12-31) — Net Income: -118674000.00
ZYME income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -118674000.00
ZYME income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -118674000.00
ZYME income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -118674000.00
ZYME income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -118674000.00
ZYME cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -118674000.00
ZYME income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -118674000.00
ZYME cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -1603000.00
ZYME income_statement (annual, 2023-12-31) — Net Interest Income: 19705000.00
ZYME cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -203176000.00
ZYME cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -21000.00
ZYME cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -21000.00
ZYME income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 19705000.00
ZYME cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -53000.00
ZYME balance_sheet (annual, 2023-12-31) — Net PPE: 37543000.00
ZYME cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2474000.00
ZYME balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 427506000.00
ZYME balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 3615000.00
ZYME balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 36241000.00
ZYME balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 32941000.00
ZYME balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 3615000.00
ZYME balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 3300000.00
ZYME balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 7240000.00